Incidence, mortality and survival from prostate cancer in Vaud and Neuchatel, Switzerland, 1974-1994

Annals of Oncology

Volumn 9, Issue 1, 1998, Pages 31-35

  Levi, F ^a,b   La Vecchia, C ^c   Randimbison, L ^a   Erler, G ^b   Te, V C ^a   Franceschi, S ^d  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b Registre Neuchatelois des Tumeurs   (Switzerland)

^c UNIVERSITY OF MILAN   (Italy)

^d CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Cancer; Incidence; Mortality; Prostate; Registry; Screening; Survival; Time trends

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CANCER SURVIVAL; DEVELOPED COUNTRY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SWITZERLAND;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; HUMANS; INCIDENCE; MALE; PROSTATIC NEOPLASMS; SURVIVAL RATE; SWITZERLAND;

EID: 0031929317     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008209005622     Document Type: Article

References (30)

1. Corder EH, Chute CG, Guess HA et al. Prostate cancer in Rochester, Minnesota (USA), from 1935 to 1989: Increase in incidence related to more complete ascertainment. Cancer Causes Control 1994; 5: 207-21.
2. Hsing AW, Devesa S. Prostate cancer mortality in the United States by cohort year of birth, 1865-1940. Cancer Epidemiology, Biomarkers & Prevention 1994; 3: 527-30.
3. Danley KL, Richardson JL, Bernstein L et al. Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ ethnic group in Los Angeles County, California (United States). Cancer Causes Control 1995; 6: 492-8.
4. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. J Am Med Ass 1995; 273: 548-52.
5. Merrill RM, Potosky AL, Feuer EJ. Changing trends in US prostate cancer incidence rates. J Natl Cancer Inst 1996; 88: 1683-5.
6. Pezzino G, Remington PL, Anderson HA et al. Trends in the surgical treatment of prostate cancer in Wisconsin, 1989-1991. J Natl Cancer Inst 1994; 86: 1083-6.
7. Polednak AP. Trends in prostate carcinoma incidence in Connecticut (1988-1994) by age and race. Cancer 1997; 79: 99-103.
8. Lu-Yao GL, Greenberg ER. Changes in prostate cancer incidence and treatment in USA. Lancet 1994; 343: 251-4.
9. Boyle P. Prostate cancer: Creation and control of an epidemic (Editorial). J Epidemiol Biostat 1996; 1: 65-7.
10. Stephenson RA, Smart CR, Mineau GP et al. The fall in incidence of prostate carcinoma. On the down side of a prostate specific antigen induced peak in incidence - data from the Utah Cancer Registry. Cancer 1995; 77: 1342-8.
11. Gann PH. Interpreting recent trends in prostate cancer incidence and mortality (Editorial). Epidemiology 1997; 8: 117-9.
12. Merrill RM, Brawley OW. Prostate cancer incidence and mortality rates among White and Black men. Epidemiology 1997; 8: 125-31.
13. Jacobsen SJ, Katusic SK, Bergstralh EJ et al. Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. J Am Med Ass 1995; 274: 1445-9.
14. Tretli S, Egeland A, Haldorsen T et al. Prostate cancer - look to Denmark? JNCI 1996; 88: 128.
15. Van der Gulden JWJ, Kiemeney LALM, Verbeek ALM, Straatman H. Mortality trends from prostate cancer in the Netherlands (1950-1989). The Prostate 1994; 24; 33-8.
16. Majeed PA, Burgess NA. Trends in death rates and registration rates for prostate cancer in England and Wales. Br J Urol 1994; 73: 377-81.
17. Harvei S, Tretli S, Langmark F. Cancer of the prostate in Norway 1957-1991 - a descriptive study. Eur J Cancer 1996; 32A: 111-7, 1996.
18. McCaul K, Luke CG, Roder DM. Trends in prostate cancer incidence and mortality rates in South Australia, 1977-1993. Med J Aust 1995; 162: 520-2.
19. McCredie M, Coates M, Churches T, Rogers J. Rising incidence of prostate cancer in Australia: A result of screening. J Epidemiol Biostat 1996; 1: 99-105.
20. Kosary CL, Ries LAG, Miller AB, Hankey BF (eds). SEER Cancer Statistics Review, 1973-1992. Tables and Graphs, National Cancer Institute. NIH publication no. 96-2789. Bethesda, MD 1995; 391-407.
21. Helgesen F, Holmberg L, Johansson J-E et al. Trends in prostate cancer survival in Sweden, 1960 through 1988: Evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst 1996; 88: 1216-21.
22. Johansson J-E, Holmberg L, Johansson S et al. Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. J Am Med Ass 1997; 277: 467-71.
23. Levi F, Lucchini F, La Vecchia C. Worldwide patterns of cancer mortality, 1985-89. Eur J Cancer Prev 1994; 3: 104-43.
24. Levi F, Te VC, Randimbison L, La Vecchia C, Randriamiharisoa A. Statistics from the registry of the Canton of Vaud, Switzerland, 1983-1987. In Parkin DM, Muir CS, Whelan SL, Gao YT et al. (eds): Cancer Incidence in Five Continents. Volume VI. IARC scientific publication no. 120. Lyon: International Agency for Research on Cancer 1992; 762-5.
25. Pellaux S, Levi F, Méan A. Statistics from the registry of the Canton of Neuchâtel, Switzerland, 1983-1987. In Parkin DM, Muir CS, Whelan SL, Gao YT et al. (eds): Cancer Incidence in Five Continents. Volume VI. IARC scientific publication no. 120. Lyon: International Agency for Research on Cancer 1992; 754-7.
26. World Health Organization. International Classification of Diseases for Oncology (ICD-O). Geneva: WHO 1976.
27. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Ass 1958; 53: 457-81.
28. Peto R, Pike MC, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Part II: Analysis and examples. Br J Cancer 1977; 35: 1-39.
29. Ederer F, Axtell MA, Cutler SJ. The relative survival rate: A statistical methodology. Natl Cancer Inst Monogr 1961; 6: 101-2.
30. Ammann P, Beer V, Bisig B et al. Enquête suisse sur la santé 1992-93. Analyse comparée Vaud-Suisse. Lausanne: Institut suisse de la santé publique (ISP) 1996; 44-6.